|
⚲
|
| Keyboard |
| Caligan Partners LP | |
|---|---|
| Firm | Caligan Partners LP |
| Address | 780 Third Avenue 30th Floor New York, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Caligan Partners LP | |||||
| Caligan Partners CV VI LP | 021-481940 | Promoter | 14.6 M | 36.0 M | |
| Caligan Partners CV III LP | 021-382666 | Promoter | 33.9 M | 42.2 M | |
| Caligan Partners CV I LP | 021-330856 | Promoter | 19.0 M | 23.8 M | |
| Caligan Partners Offshore LP | 021-433634 | Promoter | 99.3 M | ||
| Caligan Partners Onshore LP | 021-433633 | Promoter | 192.9 M | ||
| Caligan Partners CV V LP | 021-397763 | Promoter | 35.6 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Exelixis Inc EXEL
Common Stock
|
2025-11-25 | Buy | 27,532 | $43.12 | 1,187,180 |
|
Liquidia Corp LQDA
"Common Stock, $0.001 par value per share (""Common Stock"")"
|
2025-06-17 | Grant | 18,396 | $0.00 | |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2025-05-29 | Grant | 21,464 | $0.00 | |
|
Alimera Sciences Inc ALIM
"Common Stock, par value $0.01 per share (""Common Stock"")"
|
2024-09-16 | Other | 16,835,154 | ||
|
Alimera Sciences Inc ALIM
Warrants · derivative
|
2024-09-16 | Other | 800,000 | ||
|
Alimera Sciences Inc ALIM
Notional Derivative Agreements (obligation to buy) · derivative
|
2024-09-16 | Other | 1 | ||
|
Liquidia Corp LQDA
"Common Stock, $0.001 par value per share (""Common Stock"")"
|
2024-09-12 | Grant | 1,123,595 | $8.90 | 9,999,996 |
|
Liquidia Corp LQDA
Common Stock
|
2024-08-30 | Sell | 150,000 | $9.51 | 1,426,500 |
|
Liquidia Corp LQDA
"Common Stock, $0.001 par value per share (""Common Stock"")"
|
2024-08-30 | Other | 3,440,948 | ||
|
Liquidia Corp LQDA
Common Stock
|
2024-08-30 | Buy | 150,000 | $9.51 | 1,426,500 |
|
Liquidia Corp LQDA
"Common Stock, $0.001 par value per share (""Common Stock"")"
|
2024-06-20 | Grant | 20,359 | $0.00 | |
|
Exelixis Inc EXEL
Option (right to buy) · derivative
|
2024-05-31 | Grant | 42,767 | $0.00 | |
|
Exelixis Inc EXEL
Common Stock
|
2024-05-30 | Buy | 225,000 | $20.76 | 4,671,000 |
|
Exelixis Inc EXEL
Common Stock
|
2024-05-28 | Buy | 200,000 | $20.32 | 4,064,000 |
|
Exelixis Inc EXEL
Common Stock
|
2024-02-21 | Buy | 190,000 | $20.70 | 3,933,000 |
|
Liquidia Corp LQDA
"Common Stock, $0.001 par value per share (""Common Stock"")"
|
2023-12-14 | Buy | 1,117,318 | $7.16 | 7,999,997 |
|
Exelixis Inc EXEL
Common Stock
|
2023-11-27 | Buy | 120,409 | $21.61 | 2,602,038 |
|
Exelixis Inc EXEL
Common Stock
|
2023-11-27 | Sell | 120,409 | $21.61 | 2,602,038 |
|
Alimera Sciences Inc ALIM
Common Stock
|
2023-09-14 | Buy | 579,000 | $3.39 | 1,962,810 |
|
Alimera Sciences Inc ALIM
Notional Derivative Agreements (obligation to buy) · derivative
|
2023-09-14 | Other | 1 | ||
| showing 20 of 56 most recent transactions | |||||